Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B lymphocyte/carcinoma antigen (BLCa): functional study in B cells.

H Zola1, S Barclay, V Furness

  • 1Department of Clinical Immunology, Flinders Medical Centre, Australia.

Immunology and Cell Biology
|January 1, 1988
PubMed
Summary

This study identifies BCa, a novel B cell antigen distinct from CD markers. The monoclonal antibody MA6 targeting BCa inhibits B cell proliferation, offering new insights into B cell biology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular weight of onuphic acid.

Biopolymers·2017
Same author

The surface antigens of human B lymphocytes.

Immunology today·2014
Same author

Monoclonal antibodies to B cells.

Immunology today·2014
Same author

Cytokine receptors : qualitative and quantitative analysis.

Methods in molecular medicine·2011
Same author

Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients.

Cytokine·2010
Same author

CD 271 (P75 neurotrophin receptor).

Journal of biological regulators and homeostatic agents·2008

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • B cell surface antigens play crucial roles in lymphocyte function and are targets for therapeutic intervention.
  • Existing B cell markers, classified by clusters of differentiation (CD), provide a framework for understanding B cell subsets and activation states.

Purpose of the Study:

  • To characterize a novel B cell antigen, BCa, and determine its distinctness from known CD markers.
  • To investigate the expression of BCa on activated and differentiating B cells.
  • To evaluate the functional impact of targeting BCa with the monoclonal antibody MA6 on B cell proliferation.

Main Methods:

  • Utilized monoclonal antibody MA6 to identify and characterize BCa.
  • Compared BCa with CDw40 antigens using molecular weight and expression patterns.

Related Experiment Videos

  • Assessed BCa expression on tonsil B cells stimulated with anti-Ig, IL-4, LMW-BCGF, and BCDF.
  • Investigated the effect of MA6 on B cell proliferation and response to stimuli.

    • Main Results:

    • Demonstrated that BCa is a distinct antigen from known CD markers, including CDw40.
    • Observed an increase in BCa expression upon stimulation with low molecular weight B Cell Growth Factor (LMW-BCGF).
    • MA6 exhibited an antibody-dose-dependent anti-proliferative effect on B cells without affecting responses to other stimuli like IL-4, LMW-BCGF, or BCDF.

    Conclusions:

    • BLCa represents a novel B cell surface antigen, distinguishable from established CD markers.
    • Targeting BCa with MA6 demonstrates an inhibitory effect on B cell proliferation, suggesting its potential role in regulating B cell growth.
    • These findings contribute to a deeper understanding of B cell surface markers and their functional implications in B cell biology and potentially in carcinomas.